Impact of Body Mass Index on Robotic Surgery Outcomes in Early-Stage Endometrial Cancer: A Retrospective Cohort Study
Cancers · 05.11.2025 · 17 (21) · 3570
DOI: 10.3390/cancers17213570 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cancers, online erschienen am 05.11.2025. Verfasst von Dimitrios Papageorgiou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Athens Naval and Veterans Hospital, 11521 Athens, Greece. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Obesity is a well-established risk factor for endometrial cancer and presents challenges for surgical management. Robotic-assisted surgery offers a minimally invasive approach with potential benefits for obese patients. This study sought to assess the impact of body mass index (BMI) on surgical performance and short-term outcomes in patients undergoing robotic surgery for early-stage endometrial cancer, focusing on follow-up and perioperative treatment.
Methods
A retrospective analysis was conducted on 54 patients with early-stage endometrial cancer who underwent a robotic total hysterectomy, bilateral salpingo-oophorectomy, and indocyanine green sentinel lymph node biopsy between January 2021 and December 2024 at two tertiary centers. Patients were stratified by body mass index. Surgical variables, sentinel lymph node detection rates, peri- and postoperative complications, length of hospital stay, and short-term oncologic outcomes were assessed. Statistical comparisons were performed using ANOVA, chi-square tests, and Pearson’s correlation analysis.
Results
The mean patient age was 59.7 years, with a mean BMI of 31.1 kg/m2. Bilateral sentinel lymph node detection was successful in 87% of cases, with no significant differences between BMI groups. Console time, hospital stay, and complication rates were comparable across BMI categories. Console time positively correlated with the number of lymph nodes removed (r = 0.302, p = 0.026), but not with BMI. At a mean follow-up of 24.4 months, no recurrences were observed.
Conclusions
Robotic surgery for early-stage endometrial cancer is safe and effective regardless of BMI, including in patients with Class III obesity. BMI does not negatively impact surgical or short-term oncologic outcomes, supporting robotic surgery as an optimal approach in obese endometrial cancer patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology, Athens Naval and Veterans Hospital, 11521 Athens, Greece.
- 1st Gynecology Department, Metropolitan General Hospital, 15562 Athens, Greece.
- 1st Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, 11527 Athens, Greece.
- Department of Obstetrics and Gynecology, EmbryoClinic IVF, 55133 Thessaloniki, Greece.
- 2nd Department of Surgery, Laiko General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
ORCID-Profile: Dimitrios Papageorgiou, Eleftherios Zachariou, Ioakeim Sapantzoglou, Elias Tsakos, Emmanouil M Xydias
Zitieren
APA
Papageorgiou, D., Zachariou, E., Sapantzoglou, I., Tsakos, E., Xydias, E. M., Dimitroulis, D., & Plevris, N. (2025). Impact of Body Mass Index on Robotic Surgery Outcomes in Early-Stage Endometrial Cancer: A Retrospective Cohort Study. Cancers, 17(21), 3570. https://doi.org/10.3390/cancers17213570
Vancouver
Papageorgiou D, Zachariou E, Sapantzoglou I, Tsakos E, Xydias EM, Dimitroulis D, et al. Impact of Body Mass Index on Robotic Surgery Outcomes in Early-Stage Endometrial Cancer: A Retrospective Cohort Study. Cancers. 2025;17(21):3570. doi:10.3390/cancers17213570
BibTeX
@article{Papageorgiou2025,
author = {Papageorgiou, Dimitrios and Zachariou, Eleftherios and Sapantzoglou, Ioakeim and Tsakos, Elias and Xydias, Emmanouil M and Dimitroulis, Dimitrios and Plevris, Nikolaos},
title = {Impact of Body Mass Index on Robotic Surgery Outcomes in Early-Stage Endometrial Cancer: A Retrospective Cohort Study},
journal = {Cancers},
year = {2025},
volume = {17},
number = {21},
pages = {3570},
doi = {10.3390/cancers17213570}
}
EUVIMED